vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Clear Channel Outdoor Holdings, Inc. (CCO). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $461.5M, roughly 1.8× Clear Channel Outdoor Holdings, Inc.). Clear Channel Outdoor Holdings, Inc. runs the higher net margin — 1.7% vs 0.5%, a 1.2% gap on every dollar of revenue. On growth, Clear Channel Outdoor Holdings, Inc. posted the faster year-over-year revenue change (8.2% vs 7.5%). Over the past eight quarters, Clear Channel Outdoor Holdings, Inc.'s revenue compounded faster (18.8% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Clear Channel Outdoor Holdings, Inc. is a multinational corporation focused on outdoor advertising. The company is based in San Antonio, Texas.
ACHC vs CCO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $461.5M |
| Net Profit | $4.5M | $8.0M |
| Gross Margin | — | — |
| Operating Margin | — | 23.3% |
| Net Margin | 0.5% | 1.7% |
| Revenue YoY | 7.5% | 8.2% |
| Net Profit YoY | -50.8% | 144.8% |
| EPS (diluted) | $0.05 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $461.5M | ||
| Q3 25 | $851.6M | $405.6M | ||
| Q2 25 | $869.2M | $402.8M | ||
| Q1 25 | $770.5M | $334.2M | ||
| Q4 24 | $774.2M | $426.7M | ||
| Q3 24 | $815.6M | $375.2M | ||
| Q2 24 | $796.0M | $376.5M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $8.0M | ||
| Q3 25 | $36.2M | $-60.1M | ||
| Q2 25 | $30.1M | $9.5M | ||
| Q1 25 | $8.4M | $62.5M | ||
| Q4 24 | $32.6M | $-17.9M | ||
| Q3 24 | $68.1M | $-32.5M | ||
| Q2 24 | $78.5M | $-39.2M |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 23.3% | ||
| Q3 25 | 4.7% | 19.9% | ||
| Q2 25 | 5.8% | 19.2% | ||
| Q1 25 | 1.7% | 13.5% | ||
| Q4 24 | 4.9% | 23.5% | ||
| Q3 24 | 12.1% | 17.8% | ||
| Q2 24 | 13.4% | 18.2% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 1.7% | ||
| Q3 25 | 4.3% | -14.8% | ||
| Q2 25 | 3.5% | 2.4% | ||
| Q1 25 | 1.1% | 18.7% | ||
| Q4 24 | 4.2% | -4.2% | ||
| Q3 24 | 8.4% | -8.7% | ||
| Q2 24 | 9.9% | -10.4% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.01 | ||
| Q3 25 | $0.40 | $-0.12 | ||
| Q2 25 | $0.33 | $0.02 | ||
| Q1 25 | $0.09 | $0.13 | ||
| Q4 24 | $0.36 | $-0.03 | ||
| Q3 24 | $0.74 | $-0.07 | ||
| Q2 24 | $0.85 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $190.0M |
| Total DebtLower is stronger | $2.5B | $5.1B |
| Stockholders' EquityBook value | $2.0B | $-3.4B |
| Total Assets | $5.5B | $3.8B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $190.0M | ||
| Q3 25 | $118.7M | $155.0M | ||
| Q2 25 | $131.4M | $138.6M | ||
| Q1 25 | $91.2M | $395.8M | ||
| Q4 24 | $76.3M | $109.7M | ||
| Q3 24 | $82.1M | $201.1M | ||
| Q2 24 | $77.2M | $189.3M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $5.1B | ||
| Q3 25 | $2.3B | $5.1B | ||
| Q2 25 | $2.3B | $5.1B | ||
| Q1 25 | $2.2B | $5.3B | ||
| Q4 24 | $2.0B | $5.7B | ||
| Q3 24 | $1.9B | $5.7B | ||
| Q2 24 | $1.8B | $5.7B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $-3.4B | ||
| Q3 25 | $3.1B | $-3.5B | ||
| Q2 25 | $3.1B | $-3.4B | ||
| Q1 25 | $3.0B | $-3.4B | ||
| Q4 24 | $3.1B | $-3.6B | ||
| Q3 24 | $3.0B | $-3.6B | ||
| Q2 24 | $3.0B | $-3.6B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $3.8B | ||
| Q3 25 | $6.4B | $3.8B | ||
| Q2 25 | $6.3B | $3.8B | ||
| Q1 25 | $6.1B | $4.0B | ||
| Q4 24 | $6.0B | $4.8B | ||
| Q3 24 | $5.9B | $4.6B | ||
| Q2 24 | $5.7B | $4.5B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $56.3M |
| Free Cash FlowOCF − Capex | — | $30.3M |
| FCF MarginFCF / Revenue | — | 6.6% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 13.78× | 7.04× |
| TTM Free Cash FlowTrailing 4 quarters | — | $32.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $56.3M | ||
| Q3 25 | $73.2M | $56.2M | ||
| Q2 25 | $133.5M | $-12.6M | ||
| Q1 25 | $11.5M | $14.9M | ||
| Q4 24 | $116.7M | $29.3M | ||
| Q3 24 | $163.1M | $54.5M | ||
| Q2 24 | $171.1M | $30.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $30.3M | ||
| Q3 25 | $-63.0M | $41.4M | ||
| Q2 25 | $-34.2M | $-29.2M | ||
| Q1 25 | $-163.2M | $-10.6M | ||
| Q4 24 | $-86.8M | $-27.8M | ||
| Q3 24 | $-27.1M | $21.0M | ||
| Q2 24 | $16.9M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 6.6% | ||
| Q3 25 | -7.4% | 10.2% | ||
| Q2 25 | -3.9% | -7.2% | ||
| Q1 25 | -21.2% | -3.2% | ||
| Q4 24 | -11.2% | -6.5% | ||
| Q3 24 | -3.3% | 5.6% | ||
| Q2 24 | 2.1% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 5.6% | ||
| Q3 25 | 16.0% | 3.7% | ||
| Q2 25 | 19.3% | 4.1% | ||
| Q1 25 | 22.7% | 7.6% | ||
| Q4 24 | 26.3% | 13.4% | ||
| Q3 24 | 23.3% | 8.9% | ||
| Q2 24 | 19.4% | 6.8% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 7.04× | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | -1.32× | ||
| Q1 25 | 1.37× | 0.24× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
CCO
Segment breakdown not available.
